L. W. Brüggemann

发表

Chapter 5 Do anticoagulants affect colon cancer ?

D. Richel, C. Spek, C. J. Noorden, 2008 .

Assessing the efficacy of the Hedgehog pathway inhibitor vitamin D3 in a murine xenograft model for pancreatic cancer

C. Spek, K. Queiroz, M. Bijlsma, 2010, Cancer biology & therapy.

Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.

H. Büller, C. V. van Noorden, D. Richel, 2011, Cancer letters.

Prophylactic plasma levels of the low molecular weight heparin nadroparin does not affect colon cancer tumor development in mouse liver.

Susanne M. Smorenburg, C. V. van Noorden, D. Richel, 2010, Thrombosis research.

Long‐term thrombin inhibition promotes cancer cell extravasation in a mouse model of experimental metastasis

P. Reitsma, H. Büller, C. V. van Noorden, 2009, Journal of thrombosis and haemostasis : JTH.

Differential effects of anticoagulants on tumor development of mouse cancer cell lines B 16 , K 1735 and CT 26 in

P. Reitsma, D. Richel, C. Spek, 2009 .

Experimental melanoma metastasis in lungs of mice with congenital coagulation disorders

P. Reitsma, H. Versteeg, C. Spek, 2008, Journal of cellular and molecular medicine.

Chapter 4 Metastasis promoting effects of thrombin inhibitors

P. Reitsma, H. Büller, D. Richel, 2008 .

The role of blood coagulation in cancer, inflammation and embryonic development

L. W. Brüggemann, 2008 .

In vivo analysis of the antimetastatic effects of anticoagulants on mouse cancer cell lines B 16 , K 1735 and CT 26

D. Richel, C. J. Noorden, O. Tellingen, 2008 .

Chapter In vivo analysis of the antimetastatic effects of anticoagulants on murine cancer cell lines B 16 , K 1735 and CT 26

P. Reitsma, D. Richel, C. Spek, 2008 .

High FVIIa levels do not promote tumor metastasis

P. Reitsma, H. Versteeg, C. Spek, 2008 .

Metastasis promoting effects of thrombin inhibitors

H. Büller, D. Richel, H. Versteeg, 2008 .

Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation.

P. Reitsma, M. Peppelenbosch, H. Versteeg, 2006, Experimental cell research.

Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice*

P. Reitsma, C. Spek, S. Schoenmakers, 2006, Critical care medicine.

Role of the FV Leiden mutation in septic peritonitis assessed in FV Leiden transgenic mice

P. Reitsma, C. Spek, A. Groot, 2006 .

Smoothened-dependent and -independent pathways in mammalian noncanonical Hedgehog signaling

M. Peppelenbosch, C. Spek, M. Bruno, 2019, The Journal of Biological Chemistry.

Alternatively spliced tissue factor in mice: induction by Streptococcus pneumoniae

P. Reitsma, J. Drijfhout, C. Spek, 2006, Journal of thrombosis and haemostasis : JTH.

Role of coagulation FVIII in septic peritonitis assessed in hemophilic mice

P. Reitsma, C. Spek, S. Schoenmakers, 2005, Journal of thrombosis and haemostasis : JTH.

Glutathione synthetase deficiency associated with antenatal cerebral bleeding

F. Groenendaal, M. Durán, L. Dorland, 2004, Journal of Inherited Metabolic Disease.

Protease-activated receptor-4 deficiency does not protect against bleomycin-induced pulmonary fibrosis in mice

K. Borensztajn, J. Duitman, C. Spek, 2012, European Respiratory Journal.

High factor VIIa levels do not promote tumor metastasis

P. Reitsma, H. Versteeg, C. Spek, 2008, Thrombosis and Haemostasis.

Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung

P. Reitsma, D. Richel, C. Spek, 2009, Clinical & Experimental Metastasis.

Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung

P. Reitsma, D. Richel, C. Spek, 2009, Clinical & Experimental Metastasis.

Protease-activated receptor 2 blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure.

K. Borensztajn, C. Spek, L. W. Brüggemann, 2010, Shock.